Regulation of Epithelial-Mesenchymal Transition by Cyrtopodion Scabrum: An in Vitro Study Against Colorectal Cancer Cells

Overview

Journal Asian Pac J Cancer Prev

Specialty Oncology

Date 2023 Aug 29

PMID 37642063

Authors

Fatemeh Khademi

Atefeh Seghatoleslam

Amin Ramezani

Zohreh Mostafavipour

Hadi Ghasemi

Affiliations

Soon will be listed here.

Abstract

Background: Natural treatment of cancer has received a lot of attention recently due to its advantages including low cost, and fewer side effects. In this study, we aimed to investigate the antimetastatic properties of Cyrtopodion scabrum, a common home gecko, through Epithelial-Mesenchymal Transition (EMT) process.

Methods: Human colon cancer HCT116 cell line was selected and allocated into the following experimental groups: untreated control, vehicle control (DMSO), Retinoic acid (RA), and two treatment groups including aqueous C.scabrum Whole Extract (CWE) and C.scabrum Cell Extract (CCE) groups. The effects of the two different extracts on the viability, migration, and morphology of HCT116 cells were investigated using MTT, colony formation, and wound healing assay as well as microscopic evaluation. We also investigated the gene expression of E-cad, N-cad, and Snail genes using Real-Time PCR analysis.

Results: Our findings revealed that CWE and CCE were toxic to the HCT116 cell line with IC50 values of 590 and 680 µg/mL, respectively. Colony formation and migration ability of cancer cells were also inhibited by the two extracts, and the morphology of the cells were determined as epithelial phenotype. Moreover, the expression of N-cad and Snail were remarkably decreased in CWE and CCE, and RA groups, while E-cad didn't change significantly as compared to the control.

Conclusion: The results suggest that C. scabrum extract (CsE) may induce its anti-cancer activity through the inhibition of cancer cell growth and the EMT process. CCE, as a valuable natural source, could be also suggested, to be used as an alternative/complementary medicine for the treatment of cancer, in clinical trials.

References

Vergara D, Valente C, Tinelli A, Siciliano C, Lorusso V, Acierno R . Resveratrol inhibits the epidermal growth factor-induced epithelial mesenchymal transition in MCF-7 cells. Cancer Lett. 2011; 310(1):1-8. DOI: 10.1016/j.canlet.2011.04.009. View

Song Y, Wang J, Li R, Li Y, Cui Z, Duan L . Gecko crude peptides induce apoptosis in human liver carcinoma cells in vitro and exert antitumor activity in a mouse ascites H22 xenograft model. J Biomed Biotechnol. 2012; 2012:743573. PMC: 3471029. DOI: 10.1155/2012/743573. View

Acharya B, Chajaroenkul W, Na-Bangchang K . β-Eudesmol Inhibits the Migration of Cholangiocarcinoma Cells by Suppressing Epithelial-Mesenchymal Transition via PI3K/AKT and p38MAPK Modulation. Asian Pac J Cancer Prev. 2022; 23(8):2573-2581. PMC: 9741878. DOI: 10.31557/APJCP.2022.23.8.2573. View

Hollestelle A, Nagel J, Smid M, Lam S, Elstrodt F, Wasielewski M . Distinct gene mutation profiles among luminal-type and basal-type breast cancer cell lines. Breast Cancer Res Treat. 2009; 121(1):53-64. DOI: 10.1007/s10549-009-0460-8. View

Riggi N, Aguet M, Stamenkovic I . Cancer Metastasis: A Reappraisal of Its Underlying Mechanisms and Their Relevance to Treatment. Annu Rev Pathol. 2017; 13:117-140. DOI: 10.1146/annurev-pathol-020117-044127. View

Liu P, Wang W, Zhou Z, Smith A, Bowater R, Wormstone I . Chemopreventive Activities of Sulforaphane and Its Metabolites in Human Hepatoma HepG2 Cells. Nutrients. 2018; 10(5). PMC: 5986465. DOI: 10.3390/nu10050585. View

Ko Y, Lee W, Joo Y, Choi Y, Kim G, Jung J . Polyphenol mixtures of Euphorbia supina the inhibit invasion and metastasis of highly metastatic breast cancer MDA-MB-231 cells. Oncol Rep. 2015; 34(6):3035-42. DOI: 10.3892/or.2015.4304. View

Diba M, Seghatoleslam A, Namavari M, Assadi S, Vakili S, Babaei Z . Potential Protective Role of Cyrtopodion Scabrum in Antioxidant Parameters in Serum and Liver of Rats with 5-FU-Induced Oxidative Damage. Arch Razi Inst. 2021; 76(1):95-105. PMC: 8410198. DOI: 10.22092/ari.2019.126702.1356. View

Nilsson G, Akhtar N, Kannius-Janson M, Baeckstrom D . Loss of E-cadherin expression is not a prerequisite for c-erbB2-induced epithelial-mesenchymal transition. Int J Oncol. 2014; 45(1):82-94. PMC: 4079157. DOI: 10.3892/ijo.2014.2424. View

10.

Zhang L, Wang X, Lai M . Modulation of epithelial-to-mesenchymal cancerous transition by natural products. Fitoterapia. 2015; 106:247-55. DOI: 10.1016/j.fitote.2015.09.013. View

11.

Grada A, Otero-Vinas M, Prieto-Castrillo F, Obagi Z, Falanga V . Research Techniques Made Simple: Analysis of Collective Cell Migration Using the Wound Healing Assay. J Invest Dermatol. 2017; 137(2):e11-e16. DOI: 10.1016/j.jid.2016.11.020. View

12.

Tsai J, Yang J . Epithelial-mesenchymal plasticity in carcinoma metastasis. Genes Dev. 2013; 27(20):2192-206. PMC: 3814640. DOI: 10.1101/gad.225334.113. View

13.

Ahmad R, Riaz M, Aldholmi M, Qureshi M, Uddin S, Bhat A . Development of a Critical Appraisal Tool (AIMRDA) for the Peer-Review of Studies Assessing the Anticancer Activity of Natural Products: A Step towards Reproducibility. Asian Pac J Cancer Prev. 2022; 22(12):3735-3740. PMC: 9080379. DOI: 10.31557/APJCP.2021.22.12.3735. View

14.

Amiri A, Namavari M, Rashidi M, Fahmidehkar M, Seghatoleslam A . Inhibitory effects of Cyrtopodion scabrum extract on growth of human breast and colorectal cancer cells. Asian Pac J Cancer Prev. 2015; 16(2):565-70. DOI: 10.7314/apjcp.2015.16.2.565. View

15.

Torre L, Siegel R, Ward E, Jemal A . Global Cancer Incidence and Mortality Rates and Trends--An Update. Cancer Epidemiol Biomarkers Prev. 2015; 25(1):16-27. DOI: 10.1158/1055-9965.EPI-15-0578. View

16.

Sung H, Ferlay J, Siegel R, Laversanne M, Soerjomataram I, Jemal A . Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries. CA Cancer J Clin. 2021; 71(3):209-249. DOI: 10.3322/caac.21660. View

17.

Flatmark K, Maelandsmo G, Martinsen M, Rasmussen H, Fodstad O . Twelve colorectal cancer cell lines exhibit highly variable growth and metastatic capacities in an orthotopic model in nude mice. Eur J Cancer. 2004; 40(10):1593-8. DOI: 10.1016/j.ejca.2004.02.023. View

18.

Babaei Z, Namavari G, Khademi F, Koohpeyma F, Rashidi M, Shafiee S . Potential Anti-Inflammatory and Growth Inhibitory Effect of Cyrtopodion scabrum Extract on Colon Cancer; An in vivo Study. Asian Pac J Cancer Prev. 2023; 24(4):1209-1216. PMC: 10352728. DOI: 10.31557/APJCP.2023.24.4.1209. View

19.

Dias D, Urban S, Roessner U . A historical overview of natural products in drug discovery. Metabolites. 2014; 2(2):303-36. PMC: 3901206. DOI: 10.3390/metabo2020303. View

20.

Kamal I, Temerik D, Yassin E, Mosad E, A H, Hussien M . Prognostic Outcome of Mesenchymal Transition Biomarkers in Correlation with EGFR Expression in Epithelial Ovarian Carcinoma Patients. Asian Pac J Cancer Prev. 2022; 23(12):4213-4225. PMC: 9971466. DOI: 10.31557/APJCP.2022.23.12.4213. View